Omnipotent (543400)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Profit growth of 89.71% and a net loss of only ₹-0 Cr suggest the bleeding has nearly stopped, at least on an absolute basis.
• Piotroski F-Score of 5/9 shows some basic fundamental indicators are not all failing.
• Tiny market cap of ₹7 Cr leaves room for a large percentage upside if any viable asset or business emerges.
• Zero dividend means no cash is being drained while the company attempts to find a new operating footing.

Concerns

• Sales growth is -100% and latest quarter revenue is ₹0 Cr: there is no operational business to value.
• ROCE is -21.75%, indicating the capital base is currently destroying value.
• Book value, debt/equity, and promoter holding are all N/A, making it impossible to measure intrinsic value or margin of safety.
• Price is at the top of the 52-week range, nearly 4x the low of ₹2.79, without any visible earnings support.

AI Analysis

Let me start with the obvious: a refinery with no sales is not a business I can value. Omnipotent's latest quarter shows revenue of ₹0 Cr and sales growth of -100%. There is no moat in the absence of revenue; there is no predictable stream to discount. The reported profit growth of 89.71% is misleading—it comes off a loss-making base, and the net profit is still ₹-0 Cr. A P/E of 0.00 is not a bargain signal; it is a placeholder because earnings power is absent. The financial health picture is equally weak. ROCE is -21.75%, meaning the capital employed is losing money, not earning it. I normally want book value and debt figures to see whether the ₹7 Cr market cap is supported by assets, but both are N/A. Promoter holding being N/A is another red flag; I prefer to see owners with a large, visible stake. The Piotroski F-score of 5/9 is mediocre—some checks pass, but it does not override the lack of top line. At ₹10.36, the stock has moved from ₹2.79 to a 52-week high without any operating news that I can see. That is Mr. Market's enthusiasm, not Graham's margin of safety. With no dividend, no earnings, and negative return on capital, this is not an investment; it is a speculative punt on something—maybe an asset, maybe a shell, maybe a story—that has not been disclosed. I will not pay for hope when the numbers show emptiness. I would only revisit Omnipotent after several quarters of actual sales, clean financials, and positive profits. Until then, the only rational rating is 'too hard'.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer